IN2012DN00399A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00399A
IN2012DN00399A IN399DEN2012A IN2012DN00399A IN 2012DN00399 A IN2012DN00399 A IN 2012DN00399A IN 399DEN2012 A IN399DEN2012 A IN 399DEN2012A IN 2012DN00399 A IN2012DN00399 A IN 2012DN00399A
Authority
IN
India
Application number
Inventor
Ulrich Kirschner
Original Assignee
Crearene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crearene Ltd filed Critical Crearene Ltd
Publication of IN2012DN00399A publication Critical patent/IN2012DN00399A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
IN399DEN2012 2009-07-24 2012-01-13 IN2012DN00399A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09009618 2009-07-24
PCT/EP2010/004458 WO2011009601A1 (en) 2009-07-24 2010-07-21 Cell protection in dialysis patients by administration of a creatine compound

Publications (1)

Publication Number Publication Date
IN2012DN00399A true IN2012DN00399A (en) 2015-08-21

Family

ID=41066061

Family Applications (1)

Application Number Title Priority Date Filing Date
IN399DEN2012 IN2012DN00399A (en) 2009-07-24 2012-01-13

Country Status (14)

Country Link
US (1) US8791078B2 (en)
EP (1) EP2456431B1 (en)
JP (1) JP5847712B2 (en)
CN (2) CN104382891B (en)
AU (1) AU2010275752B2 (en)
BR (1) BR112012001320B1 (en)
CA (1) CA2769133C (en)
EA (1) EA022387B1 (en)
ES (1) ES2790948T3 (en)
IL (1) IL217336A (en)
IN (1) IN2012DN00399A (en)
PL (1) PL2456431T3 (en)
WO (1) WO2011009601A1 (en)
ZA (1) ZA201200185B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7736328B2 (en) 2007-07-05 2010-06-15 Baxter International Inc. Dialysis system having supply container autoconnection
CN104382891B (en) * 2009-07-24 2017-04-12 克雷勒内有限公司 Cell protection in dialysis patients by administration of a creatine compound
CN102973599B (en) * 2012-12-13 2014-04-23 天津金耀集团有限公司 Peritoneal dialysis solution (lactate) composition
AU2017261342A1 (en) 2016-05-06 2018-12-13 Gambro Lundia Ab Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation using water accumulator and disposable set

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
US20030013767A1 (en) * 2001-07-13 2003-01-16 Samuel Bessman Method of treating weight loss using creatine
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
JP6130666B2 (en) * 2009-04-06 2017-05-17 クレアレン リミテッド Hemodialysis fluid and peritoneal dialysis fluid comprising one or more creatine compounds
CN104382891B (en) * 2009-07-24 2017-04-12 克雷勒内有限公司 Cell protection in dialysis patients by administration of a creatine compound

Also Published As

Publication number Publication date
EA201200181A1 (en) 2012-06-29
ZA201200185B (en) 2012-09-26
CN104382891A (en) 2015-03-04
CA2769133A1 (en) 2011-01-27
US20120135943A1 (en) 2012-05-31
CN102573828B (en) 2018-02-23
EP2456431B1 (en) 2020-03-25
EA022387B1 (en) 2015-12-30
WO2011009601A1 (en) 2011-01-27
IL217336A0 (en) 2012-02-29
PL2456431T3 (en) 2020-08-24
US8791078B2 (en) 2014-07-29
EP2456431A1 (en) 2012-05-30
CN102573828A (en) 2012-07-11
BR112012001320A2 (en) 2020-11-03
JP5847712B2 (en) 2016-01-27
BR112012001320B1 (en) 2021-10-05
AU2010275752A1 (en) 2012-02-02
CA2769133C (en) 2017-08-29
CN104382891B (en) 2017-04-12
ES2790948T3 (en) 2020-10-30
AU2010275752B2 (en) 2016-09-01
JP2013500243A (en) 2013-01-07
IL217336A (en) 2016-09-29

Similar Documents

Publication Publication Date Title
BR112012012396A2 (en)
BRPI0924307A2 (en)
BR122021004633A2 (en)
BR122017024704A2 (en)
BR112012012487A2 (en)
BR112012000665A2 (en)
BR112012009797A2 (en)
BR112012012080A2 (en)
BR112012010357A2 (en)
BR122019005883A2 (en)
BR112012002627A2 (en)
BR112012001263A2 (en)
BR112012000159A2 (en)
BRPI1004942A2 (en)
BRPI0924534A2 (en)
BR112012000255A2 (en)
BR112012000156A2 (en)
BRPI0924617A2 (en)
BR122017013721A2 (en)
BR112012016234A2 (en)
BR112012000689A2 (en)
BRPI0925022A2 (en)
BRPI0925016A2 (en)
BRPI0924020A2 (en)
IN2012DN00399A (en)